4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-041832
Director sold 10,000 shares at an average $47.37 ($473,656)
- Director acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DOBMEIER ERIC Director | 2020-07-06 | Option exercise | +10,000 | $6.32 | $63,200 | 10,000 | D |
| DOBMEIER ERIC Director | 2020-07-06 | Sale | −9,600 | $47.34 | $454,464 | 400 | D |
| DOBMEIER ERIC Director | 2020-07-06 | Sale | −400 | $47.98 | $19,192 | 0 | D |
| Derivatives | |||||||
| DOBMEIER ERIC Director | 2020-07-06 | Option exercise · Stock Option (Right to Buy) | −10,000 | 55,000 | D | ||
| Open-market sales · 10,000 sh · avg $47.37 · $473,656 | |||||||
Loading xslF345X03/doc4.xml…